Impressed me too. The street has dismissed the hsCRP reduction., which is not seen with PCSK9 drugs. One can't help but wonder what role inflammation reduction will play in preventing CV events. I also wonder if these are additive to the PCKS9 drugs.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.